These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6231146)

  • 1. Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.
    Doldi K; Manger B; Koch B; Riemann J; Hermanek P; Kalden JR
    Clin Exp Immunol; 1984 Mar; 55(3):655-63. PubMed ID: 6231146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert suppressor T cells in Crohn's disease.
    Elson CO; Graeff AS; James SP; Strober W
    Gastroenterology; 1981 Jun; 80(6):1513-21. PubMed ID: 6453036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
    Rachmilewitz D; Ligumsky M; Haimovitz A; Treves AJ
    Gastroenterology; 1982 Apr; 82(4):673-9. PubMed ID: 6949849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.
    Warnatz H; Eder E; Lackner D; Hommel G
    Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):128-42. PubMed ID: 906620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.
    Kemler BJ; Alpert E
    Clin Exp Immunol; 1980 Nov; 42(2):280-4. PubMed ID: 6451338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
    Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
    Auer IO; Ziemer E; Sommer H
    Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
    Holdstock G; Chastenay BF; Krawitt EL
    Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 production in peripheral blood mononuclear cells of patients with gastrointestinal tumors.
    Koch B; Regnat W; Solbach W; Lanz R; Hermanek P; Kalden JR
    J Clin Lab Immunol; 1984 Apr; 13(4):171-8. PubMed ID: 6610765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
    Elson CO; James SP; Graeff AS; Berendson RA; Strober W
    Gastroenterology; 1984 Mar; 86(3):569-76. PubMed ID: 6229445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.